Work History

Work History
Aug 2010 - May 2012

SVP, Therapeutics

Chromocell Corporation

Chromocell is an emerging life sciences company, founded in 2002, focused on discovery and development of new products in two business areas: Therapeutics and Flavors and Functional Ingredients. A proprietary core technology enables discovery in both areas.

Responsible for the drug discovery and development for the therapeutics programs at the company. Focussed on discovery of molecules that treat pain through blocking the Nav1.7 ion channel in neuron.

Dec 2009 - May 2012

Consultant: CMC and PreClinical Development

LifeQual Pharmaceuticals

Provided advice on manufacturing and quality control of pharmaceutical products.

Nov 2009 - May 2012

Adviser: Business Development and Strategy

O2h

Provided advice on business strategy to a company providing contract research services to the pharmaceutical industry.

Education

Education
Oct 1980 - Jul 1983

Post-Doctoral Research

Brandeis University
Sep 1978 - Sep 1980

PhD

University of London
Sep 1974 - Jun 1978

BS

University of London

Summary

With a history of serving executive roles for senior-level biopharmaceutical research and development firms, David Palling most recently served as Senior Vice President for Chromocell Corporation’s therapeutics division. He maintained responsibility for the growth of the division while providing leadership in the early discovery and pre-clinical developmental stages of development. To further the company, David Palling established a medicinal chemistry group that supplemented the firm's existing biology expertise. He also developed new strategies and implemented projects for pain, respiratory, and renal disease areas. In addition, Dr. Palling took on responsibility for operations relating to the IT and HR departments and served on the executive management committee. Previously, David Palling spent one year as an independent consultant, helping start-up companies with business plans, technology assessments, and fundraising. Prior to that, he spent seven years with Amicus Therapeutics, Inc., a biopharmaceutical company in Cranbury, New Jersey, which he joined at the company’s founding. David Palling took on a great deal of responsibility for budget, facilities, staffing, and information technology. He also established the firm’s scientific and medical advisory boards, managed its Series B financing, and organized scientific presentations to foster collaborations. Later, David Palling assisted with clinical development and regulatory affairs; manufacturing, quality, and technical operations; and IND-enabling studies. David Palling also held positions with other pharmaceutical companies, including Johnson & Johnson, Inc., J & J Pharmaceutical Research and Development, and Hoffmann-La Roche Inc. Prior to entering the workforce, he attended the University of London, where he earned a Bachelor of Science in Chemistry and a Doctorate in Organic Chemistry. Mr. Palling then studied at Brandeis University in Massachusetts, conducting research in physical organic chemistry, analytical chemistry, and solution kinetics.

Interest

<!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Calibri","sans-serif";} </style> <![endif]-->Photography, Music particularly British 70s and 80s, Elvis Costello, Clash, Jamaican ska, Scuba, Travel, Soccer, Tottenham Hotspur